Solara Active Pharma Sciences partly paid share news and announcements

BSE: 890202Pharmaceuticals & Biotechnology

Trading suspended since 2 Apr 2026

Last traded ₹308.70 on 1 Apr 2026

The company's shares trade as Solara Active Pharma Sciences (SOLARA).

Solara Active Pharma Sciences partly paid share news and announcements

127 announcements, routine notices left out, newest first. Page 3 of 3.

Mar 2025
- 26 Mar · Corporate action
  Record date for the purpose of making first call for the shares issued on Rights Basis. (opens in a new tab)
- 26 Mar · Announcement under Regulation 30 (LODR)-Meeting Updates
  Solara Active Pharma Sciences Limited had informed the Exchange that Rights Issue Commitee Meeting of the Board of Directors at its meeting held on March 26, 2025, has approved the making .... (opens in a new tab)
- 20 Mar · Meeting
  Notice of the Postal Ballot of the Company for obtaining Members' approval to consider the appointment of Mr. Sandeep Shashikantha Rao as a Managing Director and Chief Executive Officer (opens in a new tab)
Feb 2025
- 21 Feb · Disclosure
  Grant of ESOP Options. (opens in a new tab)
- 21 Feb · Closure Of Wholly Owned Subsidiary
  Closure of Wholly Owned Subsidiary of the Company. (opens in a new tab)
- 21 Feb · Management
  Resignation of Managing Director. (opens in a new tab)
- 21 Feb · Management
  Appointment and Resignation of Chief Executive officer, Appointment and Resignation of Chief Financial Officer, .... (opens in a new tab)
- 21 Feb · Management
  Appointment of a Managing Director. (opens in a new tab)
- 10 Feb · Business
  Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted. (opens in a new tab)
- 7 Feb · Announcement under Regulation 30 (LODR)-Meeting Updates
  Company in their Board Committee meeting held today (i.e.) February 07, 2025, considered the proposal to Incorporate a wholly - owned subsidiary Company. (opens in a new tab)
Jan 2025
- 29 Jan · Results
  Company is hereby submitting the Intergrated Filings -Financials for the quarter ended December 31, 2024. (opens in a new tab)
- 24 Jan · Business
  Press Release for the Board Meeting held on January 24, 2025 on Q3 of FY.25 (opens in a new tab)
- 24 Jan · Business
  There is no Deviation and Variation of Funds raised through Rights Issue for Quarter ended December 31, 2024 (opens in a new tab)
- 24 Jan · Results
  Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31, 2024 and other matters. (opens in a new tab)
- 24 Jan · Announcement Under Regulation 30 (LODR) - Update
  Board Meeting Update (opens in a new tab)
- 16 Jan · Analysts
  Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Friday, January 24, 2025, at 3:30 pm IST to discuss the Company's .... (opens in a new tab)
Nov 2024
- 12 Nov · Business
  Monitoring Agency Report for the quarter ended September 30, 2024 received from CRISIL Ratings Limited is being submitted. (opens in a new tab)
Oct 2024
Sep 2024
- 24 Sep · Meeting
  Scrutinizer's report of the Annual General Meeting held on September 20, 2024 along with the voting results .... (opens in a new tab)
- 20 Sep · Meeting
  Proceedings of Seventh Annual General Meeting held on Friday, September 20, 2024 at Bangalore, commenced at 10:00 .... (opens in a new tab)
Aug 2024
- 28 Aug · Business Responsibility and Sustainability Reporting (BRSR)
  Business Responsibility and Sustainability Reporting (BRSR) for the year ended March 31, 2024. (opens in a new tab)
- 28 Aug · Closure Of Register Of Members And Share Transfer Books
  Register of members shall remain closed from September 18, 2024 to September 20, 2024 (both days inclusive) for the purpose of Seventh Annual General Meeting of the Company. (opens in a new tab)
- 28 Aug · Meeting
  Notice of the Seventh Annual General Meeting of the Company for the financial year 2023-24 to be held on Friday, September 20, 2024 at 10.00 a.m. (opens in a new tab)
Jul 2024
- 22 Jul · Results
  Unaudited financial results for the quarter ended June 30, 2024 (opens in a new tab)